Total Pancreatectomy With Islet Autotransplantation (TPIAT) for High-Risk Patients With Pancreatic Tumors
Start Date
9/1/2026
Completion Date
1/1/2031
Summary
This is a single-center, prospective, single-arm feasibility study evaluating whether adult patients with periampullary neoplasms who are at high risk for postoperative pancreatic fistula after pancreaticoduodenectomy can be recruited and consented to undergo total pancreatectomy with islet autotransplantation as an alternative surgical approach. Feasibility will be assessed by annual accrual rate and consent yield among eligible patients approached. Participants who enroll will undergo open or robotic total pancreatectomy with islet autotransplantation. Perioperative safety, metabolic outcomes, and early oncologic outcomes will be collected prospectively through 12 months after surgery.
Eligibility Criteria
Age Range: 18 years to No maximum
Interventions
Total Pancreatectomy with Islet Autotransplantation (TPIAT)
Conditions
Locations
Johns Hopkins Hospital
Baltimore, Maryland 21287
United States